Development of an HTRF assay for HTS to identify Lck inhibitors. Comparison with SPA and streptavidin-coated plate assay

Literature Life Science

HTRF kinase assay allows high concentrations of ATP, making possible the finding of inhibitors that do not act at the ATP binding site of the kinase


This study details the development of a homogeneous time-resolved fluorescence (HTRF® ) high throughput screening assay to identify inhibitors of Lck. HTRF® was compared with scintillation proximity and streptavidin-coated plate assays. Because of the differences in the sensitivity of detection of phosphotyrosine among the three assays, different amounts of enzyme were used. However, the concentrations of the other assay components were standardized. When using similar assay conditions, the calculated IC50 values of inhibitory compounds were independent of assay format. Furthermore, filtration experiments revealed that phosphorylation of a biotinyl poly-Glu,Ala,Tyr peptide substrate was less than autophosphorylation of the Lck enzyme; this was due to the low Km value for biotinyl poly-Glu,Ala,Tyr. In the HTRF® assay, small amounts of enzyme and high concentrations of ATP could be used, thereby minimizing the effects of autophosphorylation. Higher ATP concentration would also minimize the effect of ATP competitors. Using this technology, it may be possible to find novel kinase inhibitors that do not act at the ATP binding site of protein tyrosine kinases.


J Biomol Screen. 2000;5(6):463-70.

Read on PUBMED